Stockreport

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy [Seeking Alpha]

Vaxcyte, Inc.  (PCVX) 
PDF Follow Summary Vaxcyte's stock surged this week due to promising Phase 1/2 data for its VAX-31 vaccine, showing superior immune responses compared to Pfizer's Prevn [Read more]